1. Bacterial Expression and in Vitro Refolding of a Single-Chain Fv Antibody Specific for Human Plasma Apolipoprotein B-100
- Author
-
Tae In Park, Ju Won Kwak, Myung Hoon Lee, and Yong Bok Park
- Subjects
Protein Folding ,Lysis ,Apolipoprotein B ,Genetic Vectors ,Immunoblotting ,Immunoglobulin Variable Region ,Enzyme-Linked Immunosorbent Assay ,chemical and pharmacologic phenomena ,Immunoglobulin light chain ,medicine.disease_cause ,Binding, Competitive ,Affinity chromatography ,Escherichia coli ,medicine ,Humans ,Apolipoproteins B ,Expression vector ,Dose-Response Relationship, Drug ,biology ,Chemistry ,respiratory system ,Molecular biology ,In vitro ,Biochemistry ,Apolipoprotein B-100 ,biology.protein ,Electrophoresis, Polyacrylamide Gel ,Antibody ,Plasmids ,Biotechnology - Abstract
From the cloned heavy and light chains of a murine monoclonal antibody (mAbB23) which is specific for human apolipoprotein (apo) B-100 of plasma low-density lipoproteins, a vector was designed for expression of a single-chain antibody (scFv) of mAbB23 in Escherichia coli . The expression vector was constructed so that the scFv gene (V L -linker-V H ) was expressed under the control of the T7 promoter. The inclusion body of scFv was isolated from E. coli lysate and solubilized in 6 M guanidine-hydrochloride without reducing agents, followed by refolding through slow dilution into refolding buffer. After complete removal of the remaining denaturant by dialysis, the soluble scFv was purified through an apo B-100-coupled affinity column, and an active fraction, which had an antigen-binding activity comparable with that of native Fab, was easily obtained. The expression and in vitro refolding of scFv resulted in production of an active molecule in a yield of 15โ20 mg per 1-liter flask cultivation.
- Published
- 2002